BioAge Labs Inc. (BIOA) — Financial statements
Income statement, balance sheet, and cash flow for BioAge Labs Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue & Gross Profit | |||||
| Revenue | 9 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 9 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | |||||
| R&D Expenses | 74↑25.3% | 59↑74.2% | 34↑11.0% | 31 | |
| General & Administrative Expenses | 28↑45.2% | 19↑32.0% | 15↑53.6% | 9 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 28↑45.2% | 19↑32.0% | 15↑53.6% | 9 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 102↑30.2% | 78↑61.6% | 48↑21.1% | 40 | |
| Total Costs & Expenses | 102↑30.2% | 78↑61.6% | 48↑21.1% | 40 | |
| Operating Results | |||||
| Operating Income | -93↓18.7% | -78↓61.6% | -48↓21.1% | -40 | |
| Depreciation & Amortization | 0.21↑27.5% | 0.17↑3.1% | 0.16↑25.6% | 0.13 | |
| EBITDA | -80↓16.2% | -69↓22.7% | -56↓42.0% | -39 | |
| EBIT | -80↓16.2% | -69↓22.6% | -56↓42.0% | -39 | |
| Interest & Other Income | |||||
| Net Interest Income | 12↑70.6% | 7↑235.4% | -5↓2494.2% | 0.22 | |
| Interest Income | 13↑35.9% | 10↑296.1% | 2↑422.8% | 0.47 | |
| Interest Expense | 0.70↓70.6% | 2↓69.6% | 8↑3134.0% | 0.24 | |
| Non-Operating Income | -13↓36.2% | -9↓223.4% | 8↑1669.7% | -0.49 | |
| Other Income / Expenses | 12↑71.8% | 7↑145.8% | -15↓6356.7% | 0.25 | |
| Income Before Tax | -81↓13.4% | -71↓11.4% | -64↓60.8% | -40 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | |||||
| Net Income from Continuing Operations | -81↓13.4% | -71↓11.4% | -64↓60.8% | -40 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -81↓13.4% | -71↓11.4% | -64↓60.8% | -40 | |
| Bottom-Line Net Income | -81↓13.4% | -71↓11.4% | -64↓60.8% | -40 | |
| EPS (Basic) | -2.24↑66.2% | -6.63↑22.5% | -8.55↓60.7% | -5.32 | |
| EPS (Diluted) | -2.24↑66.2% | -6.63↑22.5% | -8.55↓60.7% | -5.32 | |
| Weighted Average Shares | 36↑235.0% | 11↑43.7% | 7↑0.1% | 7 | |
| Weighted Average Diluted Shares | 36↑235.0% | 11↑43.7% | 7↑0.1% | 7 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.